Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.

Jardine, Meg J; Kotwal, Sradha S; Bassi, Abhinav; Hockham, Carinna; Jones, Mark; Wilcox, Arlen; Pollock, Carol; Burrell, Louise M; McGree, James; Rathore, Vinay; Jenkins, Christine R; Gupta, Lalit; Ritchie, Angus; Bangi, Ashpak; D'Cruz, Sanjay; McLachlan, Andrew J; Finfer, Simon; Cummins, Michelle M; Snelling, Thomas; Jha, Vivekanand

doi:10.1136/bmj-2022-072175

Title

Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.

Publication Date

2022-11-16

Author(s)

Jardine, Meg J

Kotwal, Sradha S

Bassi, Abhinav

Hockham, Carinna

Jones, Mark

Wilcox, Arlen

Pollock, Carol

Burrell, Louise M

McGree, James

Rathore, Vinay

Jenkins, Christine R

Gupta, Lalit

Ritchie, Angus

Bangi, Ashpak

D'Cruz, Sanjay

McLachlan, Andrew J

Finfer, Simon

Cummins, Michelle M

Snelling, Thomas

Jha, Vivekanand

Type of document

Journal Article

OrcId

0000-0002-0160-2375

0000-0002-3294-4087

0000-0003-0750-9179

0000-0003-2126-5350

0000-0003-1736-1702

0000-0003-4128-1796

0000-0001-7167-6495

0000-0003-1863-7539

0000-0003-4315-5072

0000-0003-2717-5647

0000-0001-7291-5961

0000-0002-8164-8786

0000-0002-1142-1754

0000-0001-8831-8002

0000-0003-4674-0242

0000-0002-2785-5864

0000-0002-1371-5975

0000-0003-4670-0638

0000-0002-8015-9470

DOI

10.1136/bmj-2022-072175

Abstract

To determine whether disrupting the renin angiotensin system with angiotensin receptor blockers will improve clinical outcomes in people with covid-19.

Link

link

Citation

BMJ (Clinical research ed.) 2022; 379

Jornal Title

BMJ (Clinical research ed.)

ISSN

1756-1833

Austin Health

Files: